We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$99.8M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$86.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$48M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$23M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.3M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$36.3M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.4M
3
AAPL icon
Apple
AAPL
+$30.2M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.6M
5
MSFT icon
Microsoft
MSFT
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BXC icon
3926
BlueLinx
BXC
$705M
$18K ﹤0.01%
+628
New +$16.1K
CATX icon
3927
Perspective Therapeutics
CATX
$354M
$18K ﹤0.01%
+4,003
New +$17.7K
CYD icon
3928
China Yuchai International
CYD
$1.71B
$18K ﹤0.01%
1,075
-3,070
-74% -$53.7K
E icon
3929
ENI
E
$79.1B
$18K ﹤0.01%
875
-749
-46% -$13.6K
EYPT icon
3930
EyePoint Inc
EYPT
$1.16B
$18K ﹤0.01%
2,810
+1,048
+59% +$4.9K
EZA icon
3931
iShares MSCI South Africa ETF
EZA
$559M
$18K ﹤0.01%
400
+207
+107% +$8.54K
LEE icon
3932
Lee Enterprises
LEE
$181M
$18K ﹤0.01%
+1,461
New +$14.4K
MRKR icon
3933
Marker Therapeutics
MRKR
$18.5M
$18K ﹤0.01%
1,215
-2,112
-63% -$32.8K
MRSN
3934
DELISTED
Mersana Therapeutics
MRSN
$18K ﹤0.01%
27
-245
-90% -$136K
NEXT icon
3935
NextDecade
NEXT
$1.8B
$18K ﹤0.01%
8,432
-13,351
-61% -$33.9K
PED icon
3936
PEDEVCO
PED
$160M
$18K ﹤0.01%
592
+340
+135% +$9.71K
PYPD icon
3937
PolyPid
PYPD
$91.7M
$18K ﹤0.01%
+60
New +$19.1K
SLP icon
3938
Simulations Plus
SLP
$370M
$18K ﹤0.01%
252
-11,772
-98% -$780K
SMMT icon
3939
Summit Therapeutics
SMMT
$11.2B
$18K ﹤0.01%
+3,783
New +$16K
SYBX
3940
DELISTED
Synlogic
SYBX
$18K ﹤0.01%
540
+469
+661% +$15K
TCI icon
3941
Transcontinental Realty Investors
TCI
$312M
$18K ﹤0.01%
772
-832
-52% -$21.4K
TPVG icon
3942
TriplePoint Venture Growth BDC
TPVG
$221M
$18K ﹤0.01%
+1,353
New +$16.4K
ZYXI
3943
DELISTED
Zynex
ZYXI
$18K ﹤0.01%
1,463
-17,929
-92% -$233K
AIFC
3944
AI Financial Corp
AIFC
$58.9M
$18K ﹤0.01%
3,694
+2,984
+420% +$12.6K
CNTG
3945
DELISTED
Centogene N.V. Common Shares
CNTG
$18K ﹤0.01%
1,601
-3,317
-67% -$38K
GRTX
3946
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$18K ﹤0.01%
1,746
-6,732
-79% -$73.6K
SCTL
3947
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$18K ﹤0.01%
6,213
-18,512
-75% -$41.7K
ORTX
3948
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$18K ﹤0.01%
426
+244
+134% +$10.9K
ZEV
3949
DELISTED
Lightning eMotors, Inc.
ZEV
$18K ﹤0.01%
+67
New +$14.8K
FRG
3950
DELISTED
Franchise Group, Inc.
FRG
$18K ﹤0.01%
597
-22,081
-97% -$584K
156 157
158
159 160

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.